The cheap mask is not the cheap mask: a supply-chain veteran on the math hospitals usually skip

NEW YORK —

A note from supply-chain veteran Jonathan Treiber reframes a question hospital materials-management teams ask every contract cycle, and usually answer wrong: what is the actual cost of the cheaper product?

The purchase-order price, Treiber writes, is the easy number to compare. The harder one is what happens after the PO — how often the product needs to be replaced, how much it adds to nursing workload, what downstream clinical or workflow cost it creates. A cheaper-per-unit item that turns over twice as fast, or that adds two minutes to every change-out, is not cheaper.

Four factors typically determine real cost-in-use:

• Consistency and clinical trust. Products that behave inconsistently erode clinician confidence and prompt workarounds.
• Durability and replacement cycle. Every replacement is a labor cost, not a free swap.
• Workflow impact. A low unit price that adds labor at the bedside is a wash, at best.
• Service and support. Training, response time, fill rate, and warranty handling all show up in operational metrics that the materials-management line item does not capture.

His conclusion is operational, not ideological. In true commodities — surgical tape, gauze, syringes, basic earloop masks — private-label is usually the right call. In categories where the product affects mobility, positioning, skin integrity, comfort, or safety, a unit-price-only decision has a way of resurfacing later as longer length-of-stay or a pressure-injury readmission.

Materials management knows this. The pressure to hit the quarterly savings target sometimes wins anyway — and the downstream cost lands on a different budget line, where nobody is looking.

Source: Jonathan Treiber, supply-chain analysis, May 2026.